Clinical Trial

Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prostate cancer. By examining these samples, researchers hope to understand how different genes in your tumor can influence treatment decisions, how your cancer progresses and the outcome of your cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-28.
Status change: Not Yet Recruiting → Recruiting 2026-02-26
Trial Details
NCT Number NCT06960798
Lead Sponsor University of Oklahoma
Conditions Prostate Cancer
Enrollment 150 participants
Start Date 2026-05-02
Primary Completion 2028-05-30 (estimated)
Study Completion 2029-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-02